Power Dissipation in Flow-controlled Ventilation
Launched by MEDICAL UNIVERSITY INNSBRUCK · Jan 16, 2024
Trial Information
Current as of May 18, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying different methods of mechanical ventilation for patients undergoing open abdominal surgery. Specifically, it compares two approaches: one that uses low tidal volume ventilation (which delivers smaller breaths) and another that customizes the ventilator settings based on each patient's needs. The main goal is to see which method is more efficient, meaning it uses less energy to keep patients breathing well and maintains proper oxygen and carbon dioxide levels in the blood.
To participate in this study, you need to be at least 18 years old, weigh more than 40 kg, and be scheduled for elective open abdominal surgery with general anesthesia. If you join, you will receive one of the two ventilation methods and then switch to the other after a short period. The study will involve monitoring your breathing and blood gas levels to understand how effectively each method works. It’s essential to know that this trial is currently recruiting participants and aims to improve care for patients receiving mechanical ventilation during surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female subjects ≥ 18 years
- • Body weight ≥ 40 kg
- • Elective open abdominal surgery under general anaesthesia - American Society of Anesthesiologists Classification I-III
- • Written informed consent
- Exclusion Criteria:
- • Emergency surgery
- • American Society of Anesthesiologists Classification IV-V
- • Female subjects known to be pregnant
- • Known participation in another interventional clinical trial
About Medical University Innsbruck
The Medical University of Innsbruck is a leading academic institution dedicated to advancing healthcare through innovative research and clinical excellence. Situated in the heart of the Austrian Alps, it combines a rich tradition of medical education with cutting-edge scientific inquiry. As a prominent sponsor of clinical trials, the university focuses on a broad spectrum of medical fields, emphasizing the translation of research findings into practical applications for patient care. With a commitment to ethical standards and rigorous methodologies, the Medical University of Innsbruck strives to enhance treatment options and improve health outcomes globally through its collaborative efforts in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Innsbruck, Tyrol, Austria
Patients applied
Trial Officials
Patrick Spraider, PhD
Principal Investigator
Medical University of Innsbruck, Department of Anesthesia and Intensive Care Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported